UC San Diego’s Entrepreneurs-in-Residence program, which currently features three savvy business professionals who help advise students on start-up ideas, has gained two additional experts.
When astronaut Scott Kelly returns to Earth on March 1, half of NASA’s first-of-its-kind study of twin astronauts and long duration space flight, researchers at University of California, San Diego School of Medicine and elsewhere will launch the mission’s next phase.
Ten teams of innovative students at UC San Diego have been awarded proof-of-concept funding to validate the product concepts behind their innovative projects.
Scripps Institution of Oceanography at UC San Diego Distinguished Professor William Gerwick received the American Society of Pharmacognosy’s Norman R. Farnsworth Research Achievement Award for his outstanding contributions to natural products research. Gerwick will accept the award during the Society’s…
As a public research university, UC San Diego is committed to the highest standards of integrity in research.
Roughly one-quarter of all Americans – an estimated 100 million adults and children – have nonalcoholic fatty liver disease (NAFLD), a chronic condition that can lead to cirrhosis, liver cancer and liver failure. Combining a diverse array of basic science, biomarkers, imaging and clinical efforts,…
Some of the most prominent scientists conducting very “timely” research are coming to campus.
Twenty-two University of California, San Diego scientists and physicians are among the 2015 listing of “The World’s Most Influential Scientific Minds,” an annual compendium of “Highly Cited Researchers” by Thomson Reuters, a multinational mass media and information company.
Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego have entered into a research collaboration with Janssen Research & Development, LLC (Janssen R&D), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to identify new therapeutic…
A team of researchers, with the aid of the Gordon supercomputer at the San Diego Supercomputer Center based at UC San Diego, has identified a class of possible antibiotics with the potential to disable previously drug-resistant bacteria.